TOP2A is one of the genes closely related to HER2 and its protein product, topoisomerase II α, is the molecular target of anthracycline treatment.[78] Brase et al[79] showed that TOP2A RNA is a powerful prognostic marker in BC and is also connected with a favorable response to anthracyclin-based therapy. Here, TOP2A is linked to breast cancer.